First-in-human Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Doses of BCD-121 in Healthy Subjects
- First Posted Date
- 2017-04-06
- Last Posted Date
- 2017-07-17
- Lead Sponsor
- Biocad
- Target Recruit Count
- 28
- Registration Number
- NCT03103451
First-in-human Study of Safety, Pharmacokinetics and Pharmacodynamics of Various Doses of BCD-089 in Healthy Subjects
- First Posted Date
- 2017-04-06
- Last Posted Date
- 2021-02-26
- Lead Sponsor
- Biocad
- Target Recruit Count
- 19
- Registration Number
- NCT03103438
- Locations
- 🇷🇺
LLC BioEk, Saint-Petersburg, Russian Federation
Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer
- First Posted Date
- 2017-02-27
- Last Posted Date
- 2018-03-13
- Lead Sponsor
- Biocad
- Target Recruit Count
- 6
- Registration Number
- NCT03065010
- Locations
- 🇷🇺
N.N. Blokhin Russian Cancer Research Center, Sankt Petersburg, Russian Federation
A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors
- First Posted Date
- 2017-02-10
- Last Posted Date
- 2018-08-31
- Lead Sponsor
- Biocad
- Target Recruit Count
- 15
- Registration Number
- NCT03050047
- Locations
- 🇷🇺
State budgetary health care institution "St. Petersburg Clinical Scientific and Practical Center of Specialized Medical Assistance (Oncological)", Sankt Petersburg, Russian Federation
🇷🇺"Russian Cancer Research Center named after N.N. Blokhin "of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
🇷🇺LLC BioEk, Saint-Petersburg, Russian Federation
Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2018-12-19
- Lead Sponsor
- Biocad
- Target Recruit Count
- 60
- Registration Number
- NCT02762799
Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis
- Conditions
- Interventions
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2019-06-14
- Lead Sponsor
- Biocad
- Target Recruit Count
- 426
- Registration Number
- NCT02762838
- Locations
- 🇧🇾
Institution of Healthcare "First Municipal Clinical Hospital", Minsk, Belarus
🇮🇳S.P Medical College & A.G. of Hospitals, Bīkaner, India
🇧🇾Institution of Healthcare "Ordena Trudovogo Krasnogo Znameni Regional Clinical Hospital", Minsk, Belarus
Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis
- Conditions
- Interventions
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2018-02-23
- Lead Sponsor
- Biocad
- Target Recruit Count
- 199
- Registration Number
- NCT02762812
- Locations
- 🇷🇺
North-Western State Medical University n.a. I.I.Mechnikov, St.Petersburg, Russian Federation
Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2021-11-01
- Lead Sponsor
- Biocad
- Target Recruit Count
- 88
- Registration Number
- NCT02763111
Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2021-09-08
- Lead Sponsor
- Biocad
- Target Recruit Count
- 344
- Registration Number
- NCT02762955
- Locations
- 🇷🇺
BIOCAD, Saint Petersburg, Strelna, Russian Federation
International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- Biocad
- Target Recruit Count
- 120
- Registration Number
- NCT02762994
- Locations
- 🇷🇺
BIOCAD, Saint Petersburg, Strelna, Russian Federation